Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
11 studies found for:    implantable cardioverter defibrillator OR ICD | Open Studies | NIH, U.S. Fed
Show Display Options
Download search resultsDownload the search results for:
implantable cardioverter defibrillator OR ICD | Open Studies | NIH, U.S. Fed (11 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Not yet recruiting Efficacy and Safety of ICD Implantation in the Elderly
Conditions: Cardiomyopathy;   Coronary Artery Disease;   Congestive Heart Failure;   Myocardial Infarction
Interventions: Device: Implantable Cardioverter Defibrillator;   Other: Optimal standard of care
2 Recruiting Positive Therapy for Autonomic Function & Mood in ICD Patients
Conditions: Ventricular Arrhythmia;   Implantable Cardioverter Defibrillator
Interventions: Behavioral: Quality of Life Therapy (QOLT);   Behavioral: Heart Healthy Education (HHE)
3 Recruiting An Intervention to Improve Implantable Cardioverter-Defibrillator Deactivation Conversations
Conditions: Communication;   Heart Failure
Interventions: Behavioral: Communication training for cardiologists.;   Other: Control arm
4 Unknown  Stress Reduction Program to Reduce Abnormal Heart Rhythms Treated With Implantable Cardioverter Defibrillators (The RISTA Study)
Condition: Arrhythmias, Cardiac
Intervention: Behavioral: Stress reduction treatment (SRT) program
5 Recruiting A Study of Symptoms and Quality of Life in Patients With Implantable Cardiac Defibrillators (ICDs) and Their Caregivers
Conditions: Quality of Life;   Implantable Cardiac Defibrillators;   ICDs
Intervention: Behavioral: Quality of life
6 Recruiting Vaccine Therapy and Trastuzumab With or Without Polysaccharide-K in Treating Patients With Stage IV HER2 Positive Breast Cancer
Conditions: HER2-positive Breast Cancer;   Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Biological: HER-2/neu intracellular domain protein;   Biological: trastuzumab;   Other: placebo;   Biological: polysaccharide-K;   Other: laboratory biomarker analysis
7 Recruiting Inflammation, Cardiac Sympathetic Innervation, and Arrhythmic Sudden Death
Conditions: Ischemic Cardiomyopathy;   Dilated Cardiomyopathy;   Inflammation;   Sudden Cardiac Death
Intervention:
8 Not yet recruiting Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC)
Conditions: Dilated Cardiomyopathy (DCM);   Ischemic Cardiomyopathy;   Nonischemic Cardiomyopathy;   Heart Failure
Intervention: Biological: Allogeneic Cardiosphere-Derived Cells (CDCs)
9 Recruiting A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With Non-neuroblastoma, GD2+ Solid Tumors
Conditions: Sarcoma;   Osteosarcoma;   Rhabdomyosarcoma;   Ewing Sarcoma;   Melanoma
Interventions: Biological: Anti-GD2-CAR engineered T cells;   Drug: AP1903;   Drug: Cyclophosphamide
10 Recruiting INCB024360 Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Primary Peritoneal Cavity Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Primary Peritoneal Cavity Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Primary Peritoneal Cavity Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Primary Peritoneal Cavity Cancer
Interventions: Drug: IDO1 inhibitor INCB024360;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis
11 Recruiting AC6 Gene Transfer for CHF
Condition: Congestive Heart Failure
Interventions: Drug: Ad5.hAC6;   Drug: Sucrose (3%)

Indicates status has not been verified in more than two years